Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma of the Cervix”

331 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 331 results

Early research (Phase 1)Study completedNCT00287911
What this trial is testing

Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Masonic Cancer Center, University of Minnesota 18
Early research (Phase 1)Study completedNCT01711515
What this trial is testing

Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+6 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT00087113
What this trial is testing

Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group
Not applicableActive Not RecruitingNCT07147361
What this trial is testing

Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Cervical Squamous Cell CarcinomaLung Squamous Cell Carcinoma+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 800
Early research (Phase 1)Looking for participantsNCT04485013
What this trial is testing

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

Who this might be right for
Cancer
Tizona Therapeutics, Inc 240
Early research (Phase 1)Ended earlyNCT04116320
What this trial is testing

Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors

Who this might be right for
MelanomaBreast CancerMerkel Cell Carcinoma+10 more
Craig L Slingluff, Jr 5
Not applicableStudy completedNCT00895349
What this trial is testing

Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial)

Who this might be right for
Cervical CancerSquamous Cell CarcinomaAdenosquamous Carcinoma+1 more
Ontario Clinical Oncology Group (OCOG) 171
Testing effectiveness (Phase 2)Study completedNCT00025233
What this trial is testing

Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix

Who this might be right for
Cervical Squamous Cell CarcinomaRecurrent Cervical Cancer
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)WithdrawnNCT00452920
What this trial is testing

Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer

Who this might be right for
Cervical Cancer
University of Miami
Early research (Phase 1)Looking for participantsNCT04389632
What this trial is testing

Sigvotatug Vedotin in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer 1,006
Early research (Phase 1)Study completedNCT04242199
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+9 more
Incyte Corporation 182
Large-scale testing (Phase 3)Study completedNCT00003945
What this trial is testing

Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 400
Testing effectiveness (Phase 2)Ended earlyNCT05563272
What this trial is testing

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Who this might be right for
Cervical CancerColorectal CancerEsophageal Cancer+16 more
Telix Pharmaceuticals (Innovations) Pty Ltd 11
Large-scale testing (Phase 3)UnknownNCT00193739
What this trial is testing

Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix

Who this might be right for
Cancer of Cervix
Tata Memorial Hospital 635
Early research (Phase 1)Study completedNCT02020707
What this trial is testing

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Who this might be right for
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more
Mayo Clinic 43
Not applicableTemporarily pausedNCT04857528
What this trial is testing

Detecting HPV DNA in Anal and Cervical Cancers

Who this might be right for
Cervical CancerAnal CancerHPV-Related Anal Squamous Cell Carcinoma+3 more
University of Chicago 20
Testing effectiveness (Phase 2)Study completedNCT03357757
What this trial is testing

Avelumab With Valproic Acid in Virus-associated Cancer

Who this might be right for
Cancer That is Associated With a Chronic Viral Infectionp16 Positive SCCHNSquamous Cell Carcinoma of the Cervix+5 more
AHS Cancer Control Alberta 39
Testing effectiveness (Phase 2)Study completedNCT01026792
What this trial is testing

Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+5 more
National Cancer Institute (NCI) 38
Early research (Phase 1)Active Not RecruitingNCT04432857
What this trial is testing

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Who this might be right for
Triple-negative Breast CancerNSCLC, Squamous or Non-SquamousUrothelial Carcinoma of the Bladder+2 more
Adlai Nortye Biopharma Co., Ltd. 63
Early research (Phase 1)Ended earlyNCT03746431
What this trial is testing

[225Ac]-FPI-1434 Injection

Who this might be right for
Advanced Solid TumoursEndometrial CancerCervical Cancer+7 more
Fusion Pharmaceuticals Inc. 78
Load More Results